Pamela L. Barnes
Board of Directors @The Fibroid Foundation
Signup · Get unlimited contacts
WORK HISTORY
Board of Directors @The Fibroid Foundation
Washington, DC, US
EDUCATION
Brown University
Bachelor of Arts (BA), Community Health
Boston University School of Medicine
Master of Arts (MA), Medical Science
University of Sussex
School of Chemistry, Physics, and Environmental Science
ABOUT PAMELA L. BARNES
I am a senior public affairs and health policy leader with deep experience shaping national and global strategies at the intersection of AI governance, health policy, and cross‑sector coalition building. My work centers on advancing equitable access, strengthening innovation ecosystems, and aligning corporate, governmental, and diplomatic priorities to drive measurable impact for patients and communities.I have built and nurtured influential partnerships with Tri‑Caucus Foundations, leading advocacy organizations, and international stakeholders, leveraging these relationships to advance healthcare access, affordability, and innovation. By engaging directly with policymakers, community leaders, think tanks, and foreign embassies, I have ensured organizational objectives remain aligned with national and global health priorities—delivering initiatives that meaningfully shape policy outcomes.My leadership includes developing and executing enterprise strategies that integrate corporate goals with evolving U.S. and global health policy frameworks. Through evidence‑based advocacy, I translate complex regulatory, legislative, and emerging technology developments—including AI governance and health policy strategy—into actionable guidance that informs executive decision‑making and strengthens enterprise readiness.I have guided cross‑functional teams, led executive branch and Treasury‑level engagements, and mobilized multi‑sector coalitions to advance high‑priority policy objectives. This includes diplomatic engagement on oncology innovation and equity, enterprise‑wide coordination with the U.S. Department of the Treasury on foreign company interests, and national‑level leadership in responsible AI adoption across the health ecosystem.My work has been recognized with the 2022 Commercialization Innovation Award for driving oncology regulatory strategy and demonstrating visionary leadership in external affairs. Across every role, I have positioned organizations as trusted, strategic partners in health policy—expanding influence, strengthening global relationships, and delivering meaningful outcomes for patients, communities, and health systems.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.